LEE011 for Patients With CDK4/6 Pathway Activated Tumors (SIGNATURE)

Broome Oncology Broome Oncology (2), Johnson City

Fox Chase Cancer Center Dept of Medical Oncology, Philadelphia

St. Agnes Hospital St. Agnes Hospital (2), Baltimore

Shenandoah Oncology Shenadoah Oncology (2), Winchester

Wake Forest University Baptist Medical Center, Winston-Salem

Carolina Oncology Specialists, PC, Hickory

Greenville Health System ITOR - Cancer Institute, Greenville

NorthWest Georgia Oncology Centers NW Georgia Oncology, Marietta

Harbin Clinic Medical Oncology Clin. Res., Rome

Florida Hospital Cancer Institute, Orlando

University of Alabama at Birmingham, Birmingham

Tennessee Oncology Tennessee Oncology (3), Nashville

Chattanooga Oncology and Hematology Assoicates, PC Chattanooga Oncology, Chattanooga

The West Clinic Dept. of the West Clinic, Memphis

Ohio State University Medical Center Comprehensive Cancer Center, Columbus

Cleveland Clinic Foundation Taussig Cancer Institute, Cleveland

Oncology Hematology Care Inc Oncology Hematology Care 2, Cincinnati

Indiana University Indiana Univ. - Purdue Univ., Indianapolis

Northern Indiana Cancer Research Consortium No. Indiana Cancer Res., South Bend

Cancer and Hematology Centers of West Michigan Dept. of Oncology, Grand Rapids

University of Iowa Hospitals & Clinics Regulatory Contact 2, Iowa City

Aurora Research Institute Aurora Health Care, Milwaukee

Medical College of Wisconsin Cancer Center, Milwaukee

Sanford University of South Dakota Medical Center Sanford Health, Sioux Falls

Northwestern Medicine Developmental Therapeutics Institute, Chicago

Saint Luke's Hospital/Marion Bloch Neuroscience Institute St. Luke's Hospital (4), Kansas City

Research Medical Center Research Med Center (2), Kansas City

University of Arkansas/ Arkansas Cancer Research Center UA Medical Sciences, Little Rock

Oncology Consultants Oncology Group, Houston

MD Anderson Cancer Center/University of Texas MD Anderson Cancer Center (3), Houston

University of Texas Health Science Center at San Antonio Cancer Therapy & Research Ctr., San Antonio

Coastal Bend Cancer Center, Corpus Christi

Sarah Cannon Research Institute, Denver

Utah Cancer Specialists Utah Cancer Specialists (11), Salt Lake City

Intermountain Medical Center Intermountain Healthcare, Murray

New Mexico Cancer Care Alliance, Albuquerque

Comprehensive Cancer Centers of Nevada CCC of Nevada- Southwest (2), Las Vegas

PCR Oncology, Pismo Beach

University of California Davis Cancer Center UC Davis Cancer (3), Sacramento

Queen's Medical Center Queens Cancer Center, Honolulu

Oregon Health and Science University Oregon Health & Science U (56), Portland

Salem Health, Salem

Providence St. Mary Regional Cancer Center, Walla Walla

Multicare Research Institute, Tacoma

Northwest Medical Specialties Rainier Physicians, PC, Tacoma

Vista Oncology Inc. PS, Olympia

Wenatchee Valley Medical Center Wenatchee Valley, Wenatchee

Kadlec Clinic Hematology and Oncology Kadlec Clinic Hematology & Onc, Kennewick

Alaska Clinical Research, Anchorage

Arizona Oncology Associates Dept. Of Onc., Phoenix

Cancer Center at Presbyterian, Albuquerque

Danbury Hospital, Danbury

Yale University School of Medicine Smilow Cancer Hospital, New Haven

Whittingham Cancer Center Norwalk Hospital, Norwalk

Stamford Hospital Med. Oncology Hematology Res., Stamford

New England Cancer Specialists, Scarborough

Michigan Medicine University of Michigan Int. Medicine Oncology, Ann Arbor

Cooper Health System Cooper Health System (5), Camden

Rutgers Cancer Institute of New Jersey, New Brunswick

University of N C at Chapel Hill Physician Office Building, Chapel Hill

Rhode Island Hospital Rhode Island Hosp. (2), Providence